2026 NPPES data Hematology (Internal Medicine) Physician NPI 1093774465 M.D.
Verify on CMS →

Parameswaren Venugopal, M.D.

Hematology (Internal Medicine) Physician in Chicago, Illinois.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,483 in Hematology (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 247 beneficiaries · Hematology (Internal Medicine) Physician avg: 684
Generic prescribing
38%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$38.8K
31 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Parameswaren Venugopal, M.D. filed 1,783 Medicare Part D claims in 2024 as a Hematology (Internal Medicine) Physician in Chicago, Illinois, prescribing 38% generic.

2K
Part D claims, 2024
38%
generic prescribing
Likely
board-certified (heuristic)
≥82nd
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Parameswaren Venugopal, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1093774465), first enumerated 03/22/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,783 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $38.8K in reported industry payments (31 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Illinois statewide board action statistics are published annually — these figures describe aggregate state activity, not Parameswaren Venugopal, M.D.'s individual license status. Verify directly with the state medical board.

    Source: IDFPR annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1093774465 · Hematology (Internal Medicine) Physician

NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1093774465
  • ENUM-LEGACY 2006
  • TAX-NARROW 1,483
  • RX-MID 1,783
  • BOOK-THIN 49 in Illinois
  • PHOTO-ENUM Tauseef Ahmed, M.D. · 2006

Parameswaren Venugopal, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

1,783 ≥ 82nd percentile 82% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). Below this entry. 1,200–1,400: 27,889 prescribers (2%). Below this entry. 1,400–1,600: 23,183 prescribers (2%). Below this entry. 1,600–1,800: 19,917 prescribers (1%). This entry sits in this band. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Parameswaren Venugopal, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Parameswaren Venugopal, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/22/2006

NPI 1093774465

Primary specialty

Hematology (Internal Medicine) Physician

Niche

1,483 US NPIs in this specialty

Medicare Part D claims

1,783 161% vs specialty avg

2024 prescription claims

Specialty avg: 684

Specialty distribution in Illinois

How Hematology (Internal Medicine) Physician compares to other specialties among Illinois providers

Illinois providers
Clinical Social Worker5.2%Physical Therapist4.9%Mental Health Counselor4.5%Speech-Language Pathologist4.2%Student in an Organized Heal…4.1%Pharmacist4.1%Hematology (Internal Medicin…0%
Largest specialties in Illinois (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology (Internal Medicine) Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

1725 W HARRISON ST
Chicago, IL 60612

Provider Details

NPI 1093774465
Specialty Hematology (Internal Medicine) Physician
Credentials M.D.
Gender Male
NPI Issued 03/22/2006

Hospital and facility affiliations

Facilities where Parameswaren Venugopal, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Rush University Medical Group
Chicago, IL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Parameswaren Venugopal, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$38.8K

Largest payer

Genmab U.S., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Illinois IDFPR 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Parameswaren Venugopal, M.D.. To verify Parameswaren Venugopal, M.D.'s current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Parameswaren Venugopal, M.D. - brand share 62.0%
Hematology (Internal Medicine) Physician average

62% brand-name claims vs 38% generic, on 1,783 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,783
Total Claims
$20.8M
Total Drug Cost
247
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,970.9
Total Day Supply
52,844
Brand vs Generic
62% brand / 38% generic
Brand Drug Cost
$20.4M
Generic Drug Cost
$395K
Opioid Claims
12 (0.7% rate)
Antibiotic Claims
24

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
2.81
Gender Split
52% female / 48% male
Age Distribution
<65: 22, 65-74: 122, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Parameswaren Venugopal, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Revlimid
Lenalidomide
544
Acyclovir
200
Brukinsa
Zanubrutinib
129
Pomalyst
Pomalidomide
109
Ondansetron Hcl
77
Allopurinol
74
Venclexta
Venetoclax
65
Imbruvica
Ibrutinib
57
Prednisone
48
Calquence
Acalabrutinib Maleate
44

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology (Internal Medicine) Physician Overview

How Parameswaren Venugopal, M.D. fits within the Hematology (Internal Medicine) Physician landscape nationally.

1,483
Hematology (Internal Medicine) Physician Providers in US
50
States with Hematology (Internal Medicine) Physician
684
Avg Claims per Provider

Parameswaren Venugopal, M.D.'s 1,783 claims are above the specialty average of 684.

Nationwide Hematology (Internal Medicine) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Venugopal, both outside Illinois so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology (Internal Medicine) Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Venugopal.

One of 49 Hematology (Internal Medicine) Physician providers enrolled in Illinois, 5 are shown here.

Compare Hematology (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Parameswaren Venugopal, M.D.'s specialty?
Parameswaren Venugopal, M.D. specializes in Hematology (Internal Medicine) Physician and practices in Chicago, Illinois. Credentials: M.D..
How much does Parameswaren Venugopal, M.D. prescribe under Medicare Part D?
In 2024, Parameswaren Venugopal, M.D. wrote 1,783 Medicare Part D claims totaling $20.8M in drug costs for 247 beneficiaries.
Where is Parameswaren Venugopal, M.D. located?
Parameswaren Venugopal, M.D. is located at 1725 W HARRISON ST, Chicago, IL, 60612. Phone: (312) 942-5904.
What is Parameswaren Venugopal, M.D.'s NPI number?
Parameswaren Venugopal, M.D.'s National Provider Identifier (NPI) is 1093774465, issued on 03/22/2006.
Does Parameswaren Venugopal, M.D. prescribe more brand-name or generic drugs?
Parameswaren Venugopal, M.D.'s prescribing is 62% brand-name and 38% generic drugs by claim count, with $20.4M in brand drug costs.
Does Parameswaren Venugopal, M.D. prescribe opioids?
Yes, Parameswaren Venugopal, M.D. had 12 opioid claims in 2024 with an opioid prescribing rate of 0.7%.
How many Hematology (Internal Medicine) Physician providers are there in the US?
There are 1,483 Hematology (Internal Medicine) Physician providers across 50 states in the US. The average Hematology (Internal Medicine) Physician provider writes 684 Medicare Part D claims per year.
What drugs does Parameswaren Venugopal, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Parameswaren Venugopal, M.D.'s most frequently prescribed drugs include Revlimid, Acyclovir, Brukinsa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Parameswaren Venugopal, M.D. accept Medicare?
Parameswaren Venugopal, M.D. appears in CMS Medicare data with 1,783 Part D claims and 247 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Parameswaren Venugopal, M.D.'s credentials?
Parameswaren Venugopal, M.D.'s NPI is 1093774465 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.